AAOMS Annual Meeting

The US Food and Drug Administration has expanded the approval of the Sapien 3 Transcatheter Heart Valve.

The US Food and Drug Administration has expanded the approval of the Sapien 3 Transcatheter Heart Valve.

The FDA has approved a topical ocular formulation of a common antihistamine for the treatment of conjunctivitis.

The FDA has approved a topical ocular formulation of a common antihistamine for the treatment of conjunctivitis.

The FDA has approved a topical ocular formulation of a common antihistamine for the treatment of conjunctivitis.

The US Food and Drug Administration recently approved a new treatment option for patients with hemophilia B.

The US Food and Drug Administration recently approved a new treatment option for patients with hemophilia B.

The US Food and Drug Administration recently approved a new treatment option for patients with hemophilia B.

After successful results from a pivotal clinical trial, a new dosage for an integrase inhibitor was approved by the FDA.

The US Food and Drug Administration has approved a new generic option for the treatment of attention-deficit/hyperactivity disorder.